| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Challenges and solutions to ultra-high-throughput screening assay miniaturization: submicroliter fluid handling
|
Dunn, David A
|
|
2000
|
|
12S1 |
p. 84-91
8 p.
|
artikel
|
| 2 |
Combining high-throughput pharmacokinetic screens at the hits-to-leads stage of drug discovery
|
Spalding, David J.M
|
|
2000
|
|
12S1 |
p. 70-76
7 p.
|
artikel
|
| 3 |
Discovery of cytokine mimics using cell-based systems
|
Miller, Stephen G
|
|
2000
|
|
12S1 |
p. 77-83
7 p.
|
artikel
|
| 4 |
Higher-throughput automated systems for ion-channel screening
|
Senior, freelance writer, Kathryn
|
|
2000
|
|
12S1 |
p. 56-58
3 p.
|
artikel
|
| 5 |
High-throughput and virtual screening: core lead discovery technologies move towards integration
|
Good, Andrew C.
|
|
2000
|
|
12S1 |
p. 61-69
9 p.
|
artikel
|
| 6 |
High-throughput screening brings in the crops
|
Jessen, Timm
|
|
2000
|
|
12S1 |
p. 49-
1 p.
|
artikel
|
| 7 |
HTS in the new millennium
|
Burbaum, Jonathan
|
|
2000
|
|
12S1 |
p. 58-59
2 p.
|
artikel
|
| 8 |
HTS personal perspectives: small companies. Interview with George Grass
|
|
|
2000
|
|
12S1 |
p. 53-54
2 p.
|
artikel
|
| 9 |
HTS personal perspectives: small companies. Interview with Jonathan Burbaum
|
|
|
2000
|
|
12S1 |
p. 54-55
2 p.
|
artikel
|
| 10 |
HTS personal perspectives: small companies. Interview with Lev Leytes
|
|
|
2000
|
|
12S1 |
p. 51-52
2 p.
|
artikel
|
| 11 |
HTS personal perspectives: small companies. Interview with Paul England
|
|
|
2000
|
|
12S1 |
p. 50-51
2 p.
|
artikel
|
| 12 |
Introduction
|
Lawrence, Rebecca
|
|
2000
|
|
12S1 |
p. 48-
1 p.
|
artikel
|
| 13 |
Microchip-based systems for target validation and HTS
|
Sundberg, Steven A.
|
|
2000
|
|
12S1 |
p. 92-103
12 p.
|
artikel
|
| 14 |
Pseudomonas gene chips — a new research tool for cystic fibrosis
|
Dorrell, freelance writer, Sharon
|
|
2000
|
|
12S1 |
p. 55-56
2 p.
|
artikel
|
Tijdschrift beschrijving